Active ingredientChidamideCat. No. P-C126-001CAS 1616493-44-7Family · Pharmaceutical analytical standards
Chidamide
An oral histone deacetylase inhibitor of the benzamide class, discovered and developed in China: approved in December 2014 for relapsed or refractory peripheral T-cell lymphoma and in 2021 in Japan for adult T-cell leukaemia-lymphoma. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It works on epigenetics: instead of damaging DNA, it blocks only some HDAC subtypes (1, 2, 3 and 10), enzymes that decide which genes stay switched on or off in the cell.
Go to the active ingredient →Active ingredientChidamideCat. No. P-C126-001CAS 1616493-44-7
Isotopically labelledChidamide Impurity 1-d4Cat. No. P-C126-002
Isotopically labelledChidamide-d4Cat. No. P-C126-004
ImpurityChidamide Impurity 1Cat. No. P-C126-005CAS 1883690-47-8No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.